Ajanta Pharma
2,465.20
-24.20(-0.97%)
Market Cap₹2,924.20 Cr
PE Ratio33.10
IndustryHealthcare
Company Performance:
1D-0.97%
1M-4.42%
6M-9.66%
1Y-22.58%
5Y+132.62%
View Company Insightsright
More news about Ajanta Pharma
30Apr 25
Ajanta Pharma Reports 11% Growth in Q4 Profit and Revenue, Margin Contracts
Ajanta Pharma Limited announced strong Q4 FY2025 results with revenue up 11% to ₹1,170.00 crore and net profit increasing 12.50% to ₹225.00 crore. EBITDA grew 6.83% to ₹297.00 crore, though the EBITDA margin slightly decreased. The company distributed ₹700.00 crore to shareholders in FY2025, representing 76% of PAT. An earnings conference call is scheduled for April 30, 2025, to discuss the results further.
21Mar 25
Ajanta Pharma Joins FTSE All World Index, Expands Manufacturing Capacity
Ajanta Pharma has been added to the FTSE All World Index, potentially attracting $23.80 million in foreign investment. The company also announced plans to triple its liquid formulation production capacity from 6 million to 18 million bottles annually at its Pithampur site. This Rs. 92 crore expansion project, funded through internal accruals, is expected to be completed by Q1 FY 2026.
20Mar 25
Ajanta Pharma to Invest ₹92 Crore in Pithampur Facility Expansion
Ajanta Pharma Limited plans to invest ₹92 crore to expand its Pithampur manufacturing site, adding a new liquid formulation facility. The expansion will increase production capacity from 6 million to 18 million bottles per annum on a single shift basis. The project, financed through internal accruals, is set to be completed by Q1 FY 2026. This strategic move aims to meet growing global demand and alleviate current production pressures, with the existing facility operating at 175% utilization.
Ajanta Pharma
2,465.20
-24.20
(-0.97%)
1 Year Returns:-22.58%
Industry Peers
Sun Pharmaceutical
1,586.70
(-2.50%)
Divis Laboratories
5,689.50
(-3.52%)
Cipla
1,499.40
(-0.68%)
Torrent Pharmaceuticals
3,561.00
(+0.83%)
Dr Reddys Laboratories
1,253.10
(-1.73%)
Mankind Pharma
2,482.90
(-1.71%)
Zydus Life Science
975.00
(-4.34%)
Lupin
1,919.80
(-2.23%)
Alkem Laboratories
5,433.00
(-1.36%)
Aurobindo Pharma
1,090.00
(-0.64%)